RNAZ
RNAZ
NASDAQ · Biotechnology

Transcode Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$3.28
-0.20 (-5.75%)
As of Aug 15, 2:36 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +504.3% upside
Low Target $14.35
Average Target $19.82
High Target $27.60
Current Price $3.28
Current
$3.28
Target
$19.82
$14.35 $19.82 avg $27.60
Scenario Analysis
Bear Case
$14.35
337.5%
Low target
Base Case
$19.82
+504.3%
Avg target
Bull Case
$27.60
+741.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$20.99
-84.4% from high
52-Week Low
$3.30
+-0.6% from low
Target vs 52W High
$19.82
-5.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%